Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Idifarma Approved for EU-GMP Commercial Capsule Mfg. | Contract Pharma

What are you searching for?

Sign in
Breaking News

Idifarma Approved for EU-GMP Commercial Capsule Mfg.

New Bosch GKF-702 automatic capsule filling machine up and running at Pamplona plant

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Idifarma, a Spanish contract development and manufacturing organization (CDMO), has expanded its GMP manufacturing offering with the installation of new automatic capsule filling capabilities at its EU-GMP approved plant in Pamplona, Spain.

The new Bosch GKF-702 automatic capsule filling machine, which is capable of manufacturing from 3,000 to 42,000 hard capsules per hour, is now fully operational and will support Idifarma in the manufacturing of small-scale clinical and commercial batches, as well as providing the ability to simulate industrial production environments during R&D.

Successfully audited by the Spanish Medicines Agency (AEMPS) in June, the GKF-702 strengthens Idifarma’s position as a specialized contract partner for the development and manufacturing of oral solid dosage forms, with a particular focus on high potent compounds and niche pharmaceutical products requiring small batches.

The new investment includes a minibowl for small R&D batches, resulting in a more efficient use of active pharmaceutical ingredients (APIs) and less wastage. The machine also comes equipped with an industrial PC (IPC), which is 21 CFR part 11 compliant and benefits from a variety of interfaces which makes the batch documentation easier to access.

“The latest addition to our facility in Pamplona is a fantastic development for Idifarma, helping us to bolster our manufacturing capabilities and reinforce our position as a specialist CDMO for small-scale niche products in solid oral forms,” said Luis Oquiñena, general manager and co-founder of Idifarma. “The GKF-702’s modular design will help us to future proof our investment ensuring that we can add real value to our clients’ manufacturing and development projects over the coming years. It is important for us to remain versatile and flexible, however we will continue to focus on specialized low-volume and high potent pharmaceutical products which is a key differentiator for us.”

In addition to its expanded capsule filling capabilities, Idifarma has also recently invested in new analytical equipment at its Pamplona facility, including an Agilent gas chromatography system and dissolution apparatus, as well as four new Waters HPLCs to support its growing client base.  

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics